Ivor Callely
Question:130 Mr. Callely asked the Minister for Justice, Equality and Law Reform the likely developments of the European Union in the fight against drug trafficking; and if he will make a statement on the matter. [8251/98]
Vol. 491 No. 2
130 Mr. Callely asked the Minister for Justice, Equality and Law Reform the likely developments of the European Union in the fight against drug trafficking; and if he will make a statement on the matter. [8251/98]
The European Union and its member states continue to be aware of the major threat which illicit narcotic and psychotropic drugs pose to its citizens, in particular, its young people. While much has been achieved in recent years, the European Union will continue to work actively on a practical and flexible response in tackling drug trafficking, production and cultivation, preventing the use of drugs and reducing the adverse consequences of drug abuse and to ensure action against drugs remains a high priority.
Action against drugs has been a priority for the UK which currently holds the Presidency of the EU. Particular attention has been given to: priorities for 1998-9 and elaboration of the key elements of a post-1999 EU drugs strategy; co-ordination of the EU input to the preparations for the United Nations General Assembly Special Session on Drugs, 8-10 June 1998; further implementation of regional initiatives in Latin America-Caribbean and Central Asia.
Twenty EU priorities have been identified for 1998-1999. These priorities should: devote particular attention to emerging trends in the illicit production and abuse of synthetic drugs and support continued implementation of the Joint Action on new synthetic drugs; ratify and implement the Europol Convention; ratify the customs information system, CIS, and Naples II Conventions by end-1998 and end-1999 respectively; review of Joint Action on memoranda of understanding between customs and business; continue to run customs joint surveillance exercises and to encourage joint law enforcement projects; consider both the positive and negative impacts on drug misuse of new technology, in particular, the Internet.